BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36508422)

  • 1. Pterin-based small molecule inhibitor capable of binding to the secondary pocket in the active site of ricin-toxin A chain.
    Saito R; Goto M; Katakura S; Ohba T; Kawata R; Nagatsu K; Higashi S; Kurisu K; Matsumoto K; Ohtsuka K
    PLoS One; 2022; 17(12):e0277770. PubMed ID: 36508422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational change in ricin toxin A-Chain: A critical factor for inhibitor binding to the secondary pocket.
    Goto M; Higashi S; Ohba T; Kawata R; Nagatsu K; Suzuki S; Anslyn EV; Saito R
    Biochem Biophys Res Commun; 2022 Oct; 627():1-4. PubMed ID: 35998389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of ricin toxin A chain complexed with a highly potent pterin-based small-molecular inhibitor.
    Goto M; Sakamoto N; Higashi S; Kawata R; Nagatsu K; Saito R
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2219038. PubMed ID: 37259593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based identification of a ricin inhibitor.
    Yan X; Hollis T; Svinth M; Day P; Monzingo AF; Milne GW; Robertus JD
    J Mol Biol; 1997 Mar; 266(5):1043-9. PubMed ID: 9086280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The X-ray structure of ricin A chain with a novel inhibitor.
    Bai Y; Monzingo AF; Robertus JD
    Arch Biochem Biophys; 2009 Mar; 483(1):23-8. PubMed ID: 19138659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small Molecule Inhibitors Targeting the Interaction of Ricin Toxin A Subunit with Ribosomes.
    Li XP; Harijan RK; Kahn JN; Schramm VL; Tumer NE
    ACS Infect Dis; 2020 Jul; 6(7):1894-1905. PubMed ID: 32428396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragment-based identification of determinants of conformational and spectroscopic change at the ricin active site.
    Carra JH; McHugh CA; Mulligan S; Machiesky LM; Soares AS; Millard CB
    BMC Struct Biol; 2007 Nov; 7():72. PubMed ID: 17986339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 7-Substituted pterins provide a new direction for ricin A chain inhibitors.
    Pruet JM; Jasheway KR; Manzano LA; Bai Y; Anslyn EV; Robertus JD
    Eur J Med Chem; 2011 Sep; 46(9):3608-15. PubMed ID: 21641093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-domain antibodies neutralize ricin toxin intracellularly by blocking access to ribosomal P-stalk proteins.
    Czajka TF; Vance DJ; Davis S; Rudolph MJ; Mantis NJ
    J Biol Chem; 2022 Apr; 298(4):101742. PubMed ID: 35182523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide-conjugated pterins as inhibitors of ricin toxin A.
    Saito R; Pruet JM; Manzano LA; Jasheway K; Monzingo AF; Wiget PA; Kamat I; Anslyn EV; Robertus JD
    J Med Chem; 2013 Jan; 56(1):320-9. PubMed ID: 23214944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginine residues on the opposite side of the active site stimulate the catalysis of ribosome depurination by ricin A chain by interacting with the P-protein stalk.
    Li XP; Kahn PC; Kahn JN; Grela P; Tumer NE
    J Biol Chem; 2013 Oct; 288(42):30270-30284. PubMed ID: 24003229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leucine 232 and hydrophobic residues at the ribosomal P stalk binding site are critical for biological activity of ricin.
    Zhou Y; Li XP; Kahn JN; McLaughlin JE; Tumer NE
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31548364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Structural Characterization of Ricin Inhibitors Targeting Ribosome Binding Using Fragment-Based Methods and Structure-Based Design.
    Li XP; Harijan RK; Cao B; Kahn JN; Pierce M; Tsymbal AM; Roberge JY; Augeri D; Tumer NE
    J Med Chem; 2021 Oct; 64(20):15334-15348. PubMed ID: 34648707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide Mimics of the Ribosomal P Stalk Inhibit the Activity of Ricin A Chain by Preventing Ribosome Binding.
    Li XP; Kahn JN; Tumer NE
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30217009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining the Relative Binding Affinity of Ricin Toxin A Inhibitors by Using Molecular Docking and Nonequilibrium Work.
    Chaves EJF; Padilha IQM; Araújo DAM; Rocha GB
    J Chem Inf Model; 2018 Jun; 58(6):1205-1213. PubMed ID: 29750861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition and interaction of small rings with the ricin A-chain binding site.
    Yan X; Day P; Hollis T; Monzingo AF; Schelp E; Robertus JD; Milne GW; Wang S
    Proteins; 1998 Apr; 31(1):33-41. PubMed ID: 9552157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based design of ricin inhibitors.
    Jasheway K; Pruet J; Anslyn EV; Robertus JD
    Toxins (Basel); 2011 Oct; 3(10):1233-48. PubMed ID: 22069693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detecting ricin: sensitive luminescent assay for ricin A-chain ribosome depurination kinetics.
    Sturm MB; Schramm VL
    Anal Chem; 2009 Apr; 81(8):2847-53. PubMed ID: 19364139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Biological Evaluation of a Novel Small-Molecule Inhibitor of Ricin Toxin.
    Yang X; Wei A; Cao X; Wang Z; Wan H; Wang B; Peng H
    Molecules; 2024 Mar; 29(7):. PubMed ID: 38611715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular Neutralization of Ricin Toxin by Single-domain Antibodies Targeting the Active Site.
    Rudolph MJ; Czajka TF; Davis SA; Thi Nguyen CM; Li XP; Tumer NE; Vance DJ; Mantis NJ
    J Mol Biol; 2020 Feb; 432(4):1109-1125. PubMed ID: 31931008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.